Search filters

List of works by Ahmed Hamed Salem

Assessment of Clinical Drug-Drug Interactions of Elagolix, a Gonadotropin-Releasing Hormone Receptor Antagonist

scientific article published on 07 July 2020

Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphoma.

scientific article published on 2 November 2016

Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy Volunteers

scientific article published on 2 December 2016

Exposure-response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study

scientific article published on 24 September 2019

Exposure-response evaluations of venetoclax efficacy and safety in patients with non-Hodgkin lymphoma.

scientific article

Model-Informed Dosing of Venetoclax in Healthy Subjects: An Exposure-Response Analysis

scientific article published on 07 August 2019

Optimizing venetoclax dose in combination with low intensive therapies in elderly patients with newly diagnosed acute myeloid leukemia: An exposure-response analysis

scientific article published on 02 August 2019

Pharmacokinetics of the BCL-2 Inhibitor Venetoclax in Healthy Chinese Subjects.

scientific article

Science and Evidence-based Review and Approval of COVID-19 Vaccines: A Statement of Support for the U.S. FDA

scientific article published on 04 December 2020

Statins enhance efficacy of venetoclax in blood cancers.

scientific article published in June 2018

Use of depth of response to predict progression-free survival in relapsed or refractory multiple myeloma: Evaluation of results from 102 clinical trials

scientific article published on 19 April 2018

Venetoclax does not prolong the QT interval in patients with hematological malignancies: an exposure-response analysis.

scientific article published on September 2016

Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial

scientific article published in May 2018

Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial

scientific article published on 12 December 2017

Venetoclax increases intra-tumoral effector T cells and anti-tumor efficacy in combination with immune checkpoint blockade

scientific article published on 04 September 2020

Paulina is supported by:

About Paulina

Help